
JumpStart Ventures is an early-stage venture capital firm based in Cleveland, Ohio, and the investing arm of JumpStart Inc. The firm invests in high-potential technology startups — primarily B2B enterprise software and healthcare — across Ohio and the Midwest, from pre-seed through Series A.
Average disclosed round size is $10.4M (across 40 rounds with reported amounts).
Portfolio
37
Fund Size
$50M
Top Stage
Series A
Last 12 Mo
0
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
46 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| Series A | $8.5M | Jan 2026 | |
| Growth | $7.5M | Apr 2025 | |
| Seed | $2.4M | Jun 2024 | |
| Series A | $8.5M | Jun 2024 | |
| Series A | $24M | Apr 2024 | |
| Series A | $2.4M | Feb 2024 | |
| Seed | — | Jan 2024 | |
| Series A | $3M | Jan 2024 | |
| Unknown | $6M | Dec 2023 | |
| Seed | $2.7M | Nov 2023 | |
| OOptimize Health | Series B | $18M | Oct 2023 |
| Series B | $7.7M | Jan 2023 | |
| Seed | $3.5M | Jan 2023 | |
| Series A | $4.4M | Oct 2022 | |
| Series C | $20M | Sep 2022 | |
| Growth | $20M | Sep 2022 | |
| CCenterline Biomedical Inc | Series B | $33M | Jun 2022 |
| Series A | $19M | Jun 2022 | |
| Seed | $1.1M | Apr 2022 | |
| Series A | $19M | Jan 2022 | |
| RRenalis | Pre-Seed | $824K | Sep 2021 |
| Unknown | $1.7M | Jun 2021 | |
| Growth | $16M | Jan 2021 | |
| Series C | $60M | Jan 2021 | |
| Pre-Seed | $824K | Jan 2021 |
Page 1 of 2
Top Co-Investors
JobsOhio8 shared
Techstars5 shared
Ohio Innovation Fund4 shared
Plug and Play Tech Center4 shared
North Coast Ventures3 shared
First Analysis3 shared
Rev1 Ventures3 shared
Connetic Ventures3 shared
PeakSpan Capital3 shared
Cintrifuse3 shared
South Loop Ventures3 shared
Capital One Ventures3 shared
Morgan Stanley Private Credit3 shared
OCA Ventures3 shared
Early Light Ventures2 shared
Draper Triangle2 shared
Nyca Partners2 shared
Telstra Ventures2 shared
CIBC Innovation Banking2 shared
Savano Capital Partners2 shared
Last updated: 20 October 2026